SiMSen Diagnostics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
SiMSen Diagnostics General Information
Description
Developer of healthcare technology designed to maximize the potential of ultrasensitive sequencing to improve healthcare. The company's technology combines SiMSen seq with two-tailed PCR with DNA analysis specific for cancer, enabling the medical industry to customize pharma therapy for patients.
Contact Information
Website
www.simsendiagnostics.comCorporate Office
- Pepparedsleden 1
- C/o AstraZeneca BioVentureHub
- 431 83 Mölndal
- Sweden
Corporate Office
- Pepparedsleden 1
- C/o AstraZeneca BioVentureHub
- 431 83 Mölndal
- Sweden
SiMSen Diagnostics Timeline
SiMSen Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 05-May-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-2021 | $272K | $272K | Completed | Generating Revenue |
SiMSen Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SiMSen Diagnostics Patents
SiMSen Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4573214-A1 | Nucleic acid amplification | Active | 15-Aug-2022 | ||
| EP-4573214-B1 | Nucleic acid amplification | Active | 15-Aug-2022 | ||
| EP-4573214-C0 | Nucleic acid amplification | Active | 15-Aug-2022 | ||
| US-20250361550-A1 | Nucleic acid amplification | Pending | 15-Aug-2022 | ||
| WO-2024039272-A1 | Nucleic acid amplification | Inactive | 15-Aug-2022 | C12Q1/6853 |
SiMSen Diagnostics Signals
SiMSen Diagnostics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nordic Mentor Network For Entrepreneurship | Accelerator/Incubator | |||
| GOBIA Enterprises | Venture Capital | Minority | ||
| GoKap Invest | Venture Capital | Minority | ||
| JFB Invest | Venture Capital | Minority | ||
| Nordic Ignite | Angel Group | Minority |
SiMSen Diagnostics FAQs
-
When was SiMSen Diagnostics founded?
SiMSen Diagnostics was founded in 2020.
-
Where is SiMSen Diagnostics headquartered?
SiMSen Diagnostics is headquartered in Mölndal, Sweden.
-
What is the size of SiMSen Diagnostics?
SiMSen Diagnostics has 7 total employees.
-
What industry is SiMSen Diagnostics in?
SiMSen Diagnostics’s primary industry is Diagnostic Equipment.
-
Is SiMSen Diagnostics a private or public company?
SiMSen Diagnostics is a Private company.
-
What is SiMSen Diagnostics’s current revenue?
The current revenue for SiMSen Diagnostics is .
-
How much funding has SiMSen Diagnostics raised over time?
SiMSen Diagnostics has raised $1.22M.
-
Who are SiMSen Diagnostics’s investors?
Nordic Mentor Network For Entrepreneurship, GOBIA Enterprises, GoKap Invest, JFB Invest, and Nordic Ignite are 5 of 6 investors who have invested in SiMSen Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process